Literature DB >> 11828948

Treatment of ruptured hepatocellular carcinoma.

A Tanaka1, R Takeda, S Mukaihara, K Hayakawa, T Shibata, K Itoh, N Nishida, K Nakao, Y Fukuda, T Chiba, Y Yamaoka.   

Abstract

BACKGROUND: The problem of whether surgical or conservative treatment is indicated for ruptured hepatocellular carcinoma (HCC) has not been analyzed from the viewpoint of long-term development of hepatitis viral infection from liver fibrosis to liver cirrhosis. Although transcatheter arterial embolization (TAE) for hemostasis followed by two-stage hepatectomy has been established as the best treatment for ruptured HCC, there still remain difficulties in the treatment of some patients.
METHODS: Twelve patients with ruptured HCC who were surgically or conservatively treated were retrospectively analyzed in terms of modality of treatment, liver function, extension of HCC, complications, survival rate, and cause of death.
RESULTS: Tumor rupture can occur either in the early phase or in the terminal phase during the development from liver fibrosis to liver cirrhosis, while tumor rupture occurs at the advanced stage in terms of HCC extension. TAE for emergent hemostasis or prevention of re-bleeding was performed in ten patients, while TAE was contraindicated in one patient and emergent laparotomy for hemostasis was performed in one patient. In four patients, elective extended surgical resection was performed, because liver function was evaluated as clinical stage 1 according to the General rules for the clinical and pathological study of primary liver cancer of the Liver Cancer Study Group of Japan. In seven patients, conservative or medical treatment was selected, because liver function was evaluated as poor. The surgically treated group, who could tolerate extensive operation, survived longer than the conservatively treated group.
CONCLUSIONS: While TAE remains the best method to employ for hemostasis, it still has limitations. Hence, we should be mindful of other possible modalities for hemostasis and their outcomes. Rupture of HCC at an early phase in the development of liver fibrosis is a good indication for elective surgical treatment and should be distinguished from rupture in the terminal phase of liver cirrhosis, which should be treated conservatively. Although elective surgical treatment can be performed in selected patients, tumor size and location of HCC, in addition to liver function, should be taken into consideration.

Entities:  

Mesh:

Year:  2001        PMID: 11828948     DOI: 10.1007/s10147-001-8030-z

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  25 in total

1.  Ruptured peripheral cholangiocarcinoma with hemoperitoneum.

Authors:  Roland W W Chong; Alexander Y F Chung; Ivy W C Chew; Victor K M Lee
Journal:  Dig Dis Sci       Date:  2006-06-14       Impact factor: 3.199

2.  It is never too late: a deceitful gastric ulcer.

Authors:  Costantino Caroselli; Anna Tomezzoli; Cynthia Caroselli; Daniele Longo; Guglielmo Bruno
Journal:  Intern Emerg Med       Date:  2009-07-09       Impact factor: 3.397

Review 3.  Rupture of Hepatocellular Carcinoma: A Review of Literature.

Authors:  Srimanta K Sahu; Yogesh K Chawla; Radha K Dhiman; Virendra Singh; Ajay Duseja; Sunil Taneja; Naveen Kalra; Ujjwal Gorsi
Journal:  J Clin Exp Hepatol       Date:  2018-04-26

4.  One-stage liver resection for spontaneous rupture of hepatocellular carcinoma.

Authors:  Liu Hai; Peng Yong-Hong; Fu Yong; Li Ren-Feng
Journal:  World J Surg       Date:  2005-10       Impact factor: 3.352

5.  Multidisciplinary management of ruptured hepatocellular carcinoma.

Authors:  Andrzej K Buczkowski; Peter T W Kim; Stephen G Ho; David F Schaeffer; Sung I Lee; David A Owen; Alan H Weiss; Stephen W Chung; Charles H Scudamore
Journal:  J Gastrointest Surg       Date:  2006-03       Impact factor: 3.452

6.  Prognostic factors of spontaneously ruptured hepatocellular carcinoma.

Authors:  Xiang-Jun Han; Hong-Ying Su; Hai-Bo Shao; Ke Xu
Journal:  World J Gastroenterol       Date:  2015-06-28       Impact factor: 5.742

7.  Combined approach for spontaneous rupture of hepatocellular carcinoma.

Authors:  Anna Rossetto; Gian Luigi Adani; Andrea Risaliti; Umberto Baccarani; Vittorio Bresadola; Dario Lorenzin; Giovanni Terrosu
Journal:  World J Hepatol       Date:  2010-01-27

8.  Management of ruptured hepatocellular carcinoma: implications for therapy.

Authors:  Nicolò Bassi; Ezio Caratozzolo; Luca Bonariol; Cesare Ruffolo; Alessio Bridda; Luigi Padoan; Michele Antoniutti; Marco Massani
Journal:  World J Gastroenterol       Date:  2010-03-14       Impact factor: 5.742

9.  Predictors and clinical outcomes for spontaneous rupture of hepatocellular carcinoma.

Authors:  Qian Zhu; Jing Li; Jian-Jun Yan; Liang Huang; Meng-Chao Wu; Yi-Qun Yan
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

10.  Risk factors and surgical outcomes for spontaneous rupture of BCLC stages A and B hepatocellular carcinoma: a case-control study.

Authors:  Jing Li; Liang Huang; Cai-Feng Liu; Jie Cao; Jian-Jun Yan; Feng Xu; Meng-Chao Wu; Yi-Qun Yan
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.